Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSFE.L Regulatory News (SFE)

  • There is currently no data for SFE

Grant of Options

11 Apr 2017 07:00

RNS Number : 1268C
Safestyle UK PLC
11 April 2017
 

 11 April 2017

 

 

Safestyle UK plc

 

("Safestyle" or the "Company")

 

Grant of Options

 

Safestyle UK plc (AIM: SFE), the leading UK-focused retailer and manufacturer of PVCu windows and doors for the UK homeowner market announces that, on 10 April 2017, the Company granted to Steve Birmingham (Chief Executive Officer), Mike Robinson (Chief Financial Officer) and Giles Richell (Chief Operating Officer) an aggregate 131,761 nil-cost options over ordinary shares in the Company under the terms of the Safestyle UK plc 2017 Performance Share Plan.

The options are subject to the achievement of performance conditions and are exercisable from 10 April 2020 to 10 April 2027.

 

Director

Grant of new options over ordinary shares

Total number of options over ordinary shares

Director's interest in the Company's issued share capital (exc. options)

Steve Birmingham

47,935

 

212,422

4,199,846

Mike Robinson

41,913

 

185,727

316,499

Giles Richell

 

41,913

41,913

-

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details.

 

Enquiries:

 

Safestyle UK plc

Tel: 0207 653 9850

Steve Birmingham, Chief Executive Officer

 

Mike Robinson, Chief Financial Officer

 

 

 

Zeus Capital (Nominated Adviser & Joint Broker)

Tel: 0203 829 5000

Nick How / Dominic King / Andrew Jones

 

 

 

Liberum (Joint Broker)

Neil Patel

Tel: 0203 100 2100

 

 

FTI Consulting (Financial PR)

Tel: 0203 727 1000

Oliver Winters / Alex Beagley / James Styles

safestyle@fticonsulting.com

 

 

 

 

 

 

    

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

1. Steve Birmingham

2. Mike Robinson

3. Giles Richell

2

Reason for the notification

a)

Position/Status:

 

1. Chief Executive Officer

2. Chief Financial Officer

3. Chief Operating Officer

 

b)

Initial Notification/Amendment:

 

Initial Notification

3

Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor

a)

Name:

Safestyle UK plc

b)

LEI:

213800N1ZQBB3E7P8W75

 

4.

Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument:

Identification code:

Ordinary shares of £0.01

ISIN JE00BGP63272

b)

Nature of the transaction:

 

Grant of nil-cost share option

c)

Price(s) and volume(s):

Price(s)

Volume(s)

1. Nil-cost

2. Nil cost

3. Nil cost

1. 47,935

2. 41,913

3. 41,913

d)

Aggregated volume:

Price:

N/A

e)

Date of the Transaction:

10 April 2017

f)

Place of the Transaction:

Outside a trading venue

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKKDBFBKDKQD
Date   Source Headline
10th Jan 20244:50 pmRNSEGM Result & Resignation of Nomad & Joint Brokers
18th Dec 20237:00 amRNSNotice of EGM to Nominate Liquidators
3rd Nov 20237:05 amRNSFundamental Change of Business & AIM Cash Shell
30th Oct 20234:06 pmRNSAppointment of Administrators to Subsidiaries
27th Oct 20236:26 pmRNSNotice of Intention to Appoint Administrators
27th Oct 20237:30 amRNSSuspension - Safestyle UK Plc
27th Oct 20237:00 amRNSFurther Update on Process & Suspension of Trading
26th Oct 20237:00 amRNSProcess Update
16th Oct 202311:11 amRNSHolding(s) in Company
10th Oct 20236:26 pmRNSResponse to media speculation
3rd Oct 20237:00 amRNSStakeholder Engagement Update
27th Sep 20237:00 amRNSInterim Results
19th Sep 20237:00 amRNSTrading Update
16th Aug 20237:00 amRNSGrant of Options
8th Aug 20237:00 amRNSDirector/PDMR Dealing
1st Aug 20237:00 amRNSDirector/PDMR Dealing
31st Jul 20237:00 amRNSDirector/PDMR Dealing
27th Jul 20237:00 amRNSHalf Year Trading Update and Notice of Results
18th May 202312:06 pmRNSResult of 2023 Annual General Meeting
18th May 20237:00 amRNSAGM Statement
18th Apr 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
3rd Apr 20239:30 amRNSBoard Appointment
23rd Mar 20237:00 amRNSFinal Results
22nd Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSBoard Appointment
2nd Feb 20237:00 amRNSYear-End Trading Update & Notice of Results
14th Dec 20222:00 pmRNSCEO Appointment
30th Nov 20224:40 pmRNSSecond Price Monitoring Extn
30th Nov 20224:35 pmRNSPrice Monitoring Extension
29th Nov 20227:00 amRNSTrading Update
22nd Nov 202212:16 pmRNSDirector/PDMR Dealing
16th Nov 20227:00 amRNSCapital Markets Day
15th Nov 20223:43 pmRNSDirector/PDMR Shareholding
14th Oct 202212:01 pmRNSChange of PVCu profile supplier
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20223:28 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSInterim Results
5th Sep 20227:00 amRNSGrant of Options
26th Aug 20228:54 amRNSUpdate on Capital Markets Day
20th Jul 202210:40 amRNSHolding(s) in Company
24th Jun 202212:32 pmRNSExercise of Options, Director Dealing & TVR
8th Jun 20221:19 pmRNSResult of AGM
8th Jun 20227:00 amRNSAGM Statement and Notices of CMD & Interim Results
5th May 20224:23 pmRNSAnnual Report and Notice of Annual General Meeting
26th Apr 20227:00 amRNSDirector/PDMR Dealing
21st Apr 20227:00 amRNSFinal Results
28th Feb 20227:00 amRNSCyber and Trading Update and Notice of Results
28th Jan 20225:22 pmRNSCyber Incident
26th Jan 20227:00 amRNSTrading and Operations Update & Notice of Results
29th Nov 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.